- Home
- JBGS vs INMD Comparison
JBGS vs INMD Comparison
Compare JBGS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBGS
- INMD
- Stock Information
- Founded
- JBGS 2016
- INMD 2008
- Country
- JBGS United States
- INMD Israel
- Employees
- JBGS N/A
- INMD N/A
- Industry
- JBGS Real Estate Investment Trusts
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JBGS Real Estate
- INMD Health Care
- Exchange
- JBGS Nasdaq
- INMD Nasdaq
- Market Cap
- JBGS 1.4B
- INMD 1.4B
- IPO Year
- JBGS 2017
- INMD 2019
- Fundamental
- Price
- JBGS $15.60
- INMD $18.49
- Analyst Decision
- JBGS Sell
- INMD Buy
- Analyst Count
- JBGS 1
- INMD 6
- Target Price
- JBGS $17.00
- INMD $22.60
- AVG Volume (30 Days)
- JBGS 528.2K
- INMD 1.1M
- Earning Date
- JBGS 10-29-2024
- INMD 10-30-2024
- Dividend Yield
- JBGS 4.45%
- INMD N/A
- EPS Growth
- JBGS N/A
- INMD N/A
- EPS
- JBGS N/A
- INMD 1.84
- Revenue
- JBGS $567,034,000.00
- INMD $423,746,000.00
- Revenue This Year
- JBGS N/A
- INMD N/A
- Revenue Next Year
- JBGS N/A
- INMD $3.13
- P/E Ratio
- JBGS N/A
- INMD $10.06
- Revenue Growth
- JBGS N/A
- INMD N/A
- 52 Week Low
- JBGS $13.04
- INMD $14.87
- 52 Week High
- JBGS $18.86
- INMD $26.80
- Technical
- Relative Strength Index (RSI)
- JBGS 36.10
- INMD 54.87
- Support Level
- JBGS $14.78
- INMD $17.46
- Resistance Level
- JBGS $17.58
- INMD $19.85
- Average True Range (ATR)
- JBGS 0.54
- INMD 0.64
- MACD
- JBGS -0.13
- INMD -0.13
- Stochastic Oscillator
- JBGS 26.20
- INMD 53.41
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in and develops real estate assets concentrated in urban infill submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to the legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily and third-party asset management and real estate services. The company generates majority of its revenue from Commercial segment.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.